Search

Samantha L. Shterengarts

Examiner (ID: 8624, Phone: (571)270-5316 , Office: P/1626 )

Most Active Art Unit
1626
Art Unit(s)
1626, 1623, 4131
Total Applications
2403
Issued Applications
1806
Pending Applications
134
Abandoned Applications
481

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 18657597 [patent_doc_number] => 20230303506 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-09-28 [patent_title] => COMPOSITIONS AND METHODS FOR THE PREVENTION AND/OR TREATMENT OF MITOCHONDRIAL DISEASE, INCLUDING FRIEDREICH'S ATAXIA [patent_app_type] => utility [patent_app_number] => 18/087890 [patent_app_country] => US [patent_app_date] => 2022-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 83662 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18087890 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/087890
Compositions and methods for the prevention and/or treatment of mitochondrial disease, including Friedreich's ataxia Dec 22, 2022 Issued
Array ( [id] => 18837710 [patent_doc_number] => 11845773 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-12-19 [patent_title] => Trehalose analogues [patent_app_type] => utility [patent_app_number] => 18/068852 [patent_app_country] => US [patent_app_date] => 2022-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 69 [patent_figures_cnt] => 69 [patent_no_of_words] => 20084 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18068852 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/068852
Trehalose analogues Dec 19, 2022 Issued
Array ( [id] => 19784167 [patent_doc_number] => 20250057846 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-02-20 [patent_title] => COMBINATION OF A TASK1/3 CHANNEL BLOCKER WITH A MUSCARINIC RECEPTOR ANTAGONIST FOR THE TREATMENT OF SLEEP APNEA [patent_app_type] => utility [patent_app_number] => 18/722220 [patent_app_country] => US [patent_app_date] => 2022-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14235 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18722220 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/722220
COMBINATION OF A TASK1/3 CHANNEL BLOCKER WITH A MUSCARINIC RECEPTOR ANTAGONIST FOR THE TREATMENT OF SLEEP APNEA Dec 19, 2022 Pending
Array ( [id] => 18451360 [patent_doc_number] => 20230192638 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-22 [patent_title] => POLYPHENOLS DERIVATIVES [patent_app_type] => utility [patent_app_number] => 18/082401 [patent_app_country] => US [patent_app_date] => 2022-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8276 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18082401 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/082401
POLYPHENOLS DERIVATIVES Dec 14, 2022 Abandoned
Array ( [id] => 18483558 [patent_doc_number] => 20230210856 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-07-06 [patent_title] => METHODS OF SYNTHESIZING THYROID HORMONE ANALOGS AND POLYMORPHS THEREOF [patent_app_type] => utility [patent_app_number] => 18/066677 [patent_app_country] => US [patent_app_date] => 2022-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20337 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -3 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18066677 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/066677
METHODS OF SYNTHESIZING THYROID HORMONE ANALOGS AND POLYMORPHS THEREOF Dec 14, 2022 Abandoned
Array ( [id] => 19043545 [patent_doc_number] => 11932629 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-03-19 [patent_title] => KDM1A inhibitors for the treatment of disease [patent_app_type] => utility [patent_app_number] => 18/066667 [patent_app_country] => US [patent_app_date] => 2022-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 39006 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 101 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18066667 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/066667
KDM1A inhibitors for the treatment of disease Dec 14, 2022 Issued
Array ( [id] => 18294692 [patent_doc_number] => 20230104378 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-04-06 [patent_title] => FLUORINE-CONTAINING COMPOUND [patent_app_type] => utility [patent_app_number] => 18/076613 [patent_app_country] => US [patent_app_date] => 2022-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7669 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 405 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18076613 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/076613
FLUORINE-CONTAINING COMPOUND Dec 6, 2022 Pending
Array ( [id] => 18334332 [patent_doc_number] => 20230126280 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-04-27 [patent_title] => HYDANTOIN CONTAINING DEOXYURIDINE TRIPHOSPHATASE INHIBITORS [patent_app_type] => utility [patent_app_number] => 18/075316 [patent_app_country] => US [patent_app_date] => 2022-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 49972 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18075316 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/075316
Hydantoin containing deoxyuridine triphosphatase inhibitors Dec 4, 2022 Issued
Array ( [id] => 18365911 [patent_doc_number] => 20230147502 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-05-11 [patent_title] => PHOSPHONATE LINKERS AND THEIR USE TO FACILIATE CELLULAR RETENTION OF COMPOUNDS [patent_app_type] => utility [patent_app_number] => 18/061034 [patent_app_country] => US [patent_app_date] => 2022-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27584 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -48 [patent_words_short_claim] => 255 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18061034 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/061034
Phosphonate linkers and their use to facilitate cellular retention of compounds Dec 1, 2022 Issued
Array ( [id] => 18468780 [patent_doc_number] => 20230203062 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-29 [patent_title] => THERAPEUTIC COMPOUNDS AND METHODS OF USE [patent_app_type] => utility [patent_app_number] => 18/057742 [patent_app_country] => US [patent_app_date] => 2022-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 162286 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -50 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18057742 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/057742
Therapeutic compounds and methods of use Nov 20, 2022 Issued
Array ( [id] => 18265336 [patent_doc_number] => 20230086578 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-23 [patent_title] => CRYSTALLINE EPINEPHRINE MALONATE SALT [patent_app_type] => utility [patent_app_number] => 17/989859 [patent_app_country] => US [patent_app_date] => 2022-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7236 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17989859 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/989859
Crystalline epinephrine malonate salt Nov 17, 2022 Issued
Array ( [id] => 19754312 [patent_doc_number] => 20250042877 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-02-06 [patent_title] => ORGANIC COMPOUND, ORGANIC DEVICE, LIGHT-EMITTING APPARATUS, AND ELECTRONIC APPLIANCE [patent_app_type] => utility [patent_app_number] => 18/710010 [patent_app_country] => US [patent_app_date] => 2022-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 44607 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18710010 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/710010
ORGANIC COMPOUND, ORGANIC DEVICE, LIGHT-EMITTING APPARATUS, AND ELECTRONIC APPLIANCE Nov 17, 2022 Pending
Array ( [id] => 19709220 [patent_doc_number] => 20250019362 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-01-16 [patent_title] => METHOD FOR PRODUCING 2-HETEROARYLPYRIDINE COMPOUND [patent_app_type] => utility [patent_app_number] => 18/696194 [patent_app_country] => US [patent_app_date] => 2022-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4964 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -1 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18696194 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/696194
METHOD FOR PRODUCING 2-HETEROARYLPYRIDINE COMPOUND Nov 15, 2022 Pending
Array ( [id] => 18793848 [patent_doc_number] => 11827599 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2023-11-28 [patent_title] => Method of preparing ionic fluids [patent_app_type] => utility [patent_app_number] => 17/983873 [patent_app_country] => US [patent_app_date] => 2022-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 5674 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 137 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17983873 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/983873
Method of preparing ionic fluids Nov 8, 2022 Issued
Array ( [id] => 18597184 [patent_doc_number] => 20230271977 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-31 [patent_title] => EXATECAN DERIVATIVES, LINKER-PAYLOADS, AND CONJUGATES AND THEREOF [patent_app_type] => utility [patent_app_number] => 18/053459 [patent_app_country] => US [patent_app_date] => 2022-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19333 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18053459 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/053459
Exatecan derivatives, linker-payloads, and conjugates and thereof Nov 7, 2022 Issued
Array ( [id] => 18308012 [patent_doc_number] => 20230111912 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-04-13 [patent_title] => SALTS OF A PIM KINASE INHIBITOR [patent_app_type] => utility [patent_app_number] => 17/981887 [patent_app_country] => US [patent_app_date] => 2022-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31659 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17981887 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/981887
Salts of a Pim kinase inhibitor Nov 6, 2022 Issued
Array ( [id] => 19247335 [patent_doc_number] => 20240198320 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-06-20 [patent_title] => ZIF-8 ORGANOMETALLIC FRAME CATALYST COMPOSITE, AND CARBON DIOXIDE CONVERSION METHOD USING SAME [patent_app_type] => utility [patent_app_number] => 18/552589 [patent_app_country] => US [patent_app_date] => 2022-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16027 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18552589 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/552589
ZIF-8 ORGANOMETALLIC FRAME CATALYST COMPOSITE, AND CARBON DIOXIDE CONVERSION METHOD USING SAME Oct 30, 2022 Pending
Array ( [id] => 19210646 [patent_doc_number] => 11999694 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-06-04 [patent_title] => Delivery of therapeutic alkaloid compounds [patent_app_type] => utility [patent_app_number] => 17/976150 [patent_app_country] => US [patent_app_date] => 2022-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 14 [patent_no_of_words] => 57932 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17976150 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/976150
Delivery of therapeutic alkaloid compounds Oct 27, 2022 Issued
Array ( [id] => 20092030 [patent_doc_number] => 20250221966 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-07-10 [patent_title] => RXFP1 AGONISTS [patent_app_type] => utility [patent_app_number] => 18/700349 [patent_app_country] => US [patent_app_date] => 2022-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 58835 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 975 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18700349 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/700349
RXFP1 AGONISTS Oct 27, 2022 Pending
Array ( [id] => 19012954 [patent_doc_number] => 11919869 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-03-05 [patent_title] => CD73 compounds [patent_app_type] => utility [patent_app_number] => 18/050404 [patent_app_country] => US [patent_app_date] => 2022-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 42172 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 193 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18050404 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/050404
CD73 compounds Oct 26, 2022 Issued
Menu